Novogen and Marshall Edwards Sign Asset Purchase Agreement
Marshall Edwards to Acquire Intellectual Property Portfolio for $4 Million in Stock SYDNEY and SAN DIEGO, Dec. 21, 2010 /PRNewswire-FirstCall/ — Novogen Limited and Marshall Edwards, Inc. (Nasdaq:MSHL), an oncology company focused on the clinical…
